Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 10.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1999 to 2008

Recipients with Intestine Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Functioning Graft at Discharge 49 61 88 89 103 130 155 148 166 168
With Immunosuppression Info 49 61 88 89 103 127 152 148 166 167
Corticosteroids Any in Category 93.9% 96.7% 79.5% 66.3% 67.0% 74.8% 71.1% 73.6% 77.1% 78.4%
Steroids 93.9% 96.7% 79.5% 66.3% 67.0% 74.8% 71.1% 73.6% 77.1% 78.4%
Cyclosporine Any in Category 4.1% 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0% 0.0% 0.6%
Neoral 4.1% 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0% 0.0% 0.6%
Tacrolimus Any in Category 95.9% 95.1% 97.7% 95.5% 93.2% 97.6% 96.7% 98.0% 97.0% 98.8%
Tacrolimus 95.9% 95.1% 97.7% 95.5% 93.2% 97.6% 96.7% 98.0% 97.0% 98.8%
Antimetabolites Any in Category 24.5% 21.3% 10.2% 12.4% 8.7% 8.7% 12.5% 19.6% 22.9% 24.6%
Mycophenolate Mofetil 18.4% 14.8% 3.4% 11.2% 8.7% 8.7% 12.5% 18.9% 21.1% 24.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Azathioprine 6.1% 6.6% 6.8% 1.1% 0.0% 0.0% 0.0% 0.7% 1.8% 0.6%
mTOR Inhibitors Any in Category 2.0% 39.3% 21.6% 20.2% 5.8% 11.8% 12.5% 10.1% 9.0% 9.6%
Sirolimus 2.0% 39.3% 21.6% 20.2% 5.8% 11.8% 12.5% 10.1% 9.0% 9.6%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 4, 2009.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.



PDF FormatRequires Adobe Acrobat Reader